Semi-Annual Consolidated Statement Of Cash Flows

EnBio Holdings,Inc - Filing #7373356

Concept As at
2023-09-30
2023-04-01 to
2023-09-30
As at
2023-03-31
As at
2022-09-30
2022-04-01 to
2022-09-30
As at
2022-03-31
Semi-annual consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal
1,370,149,000 JPY
2,537,967,000 JPY
Interest and dividends received
17,490,000 JPY
5,989,000 JPY
Interest paid
-57,094,000 JPY
-62,898,000 JPY
Net cash provided by (used in) operating activities
1,022,064,000 JPY
2,128,386,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-679,755,000 JPY
-725,594,000 JPY
Purchase of investment securities
-935,000 JPY
-6,084,000 JPY
Loan advances
-73,585,000 JPY
-23,841,000 JPY
Other, net
-28,884,000 JPY
-11,649,000 JPY
Net cash provided by (used in) investing activities
-789,128,000 JPY
-788,451,000 JPY
Cash flows from financing activities
Proceeds from long-term borrowings
921,985,000 JPY
628,675,000 JPY
Redemption of bonds
-18,500,000 JPY
-17,500,000 JPY
Repayments of long-term borrowings
-2,038,332,000 JPY
-848,716,000 JPY
Proceeds from issuance of shares
1,056,000,000 JPY
JPY
Dividends paid
-52,914,000 JPY
-52,733,000 JPY
Net cash provided by (used in) financing activities
337,487,000 JPY
-224,788,000 JPY
Purchase of shares of subsidiaries not resulting in change in scope of consolidation
-1,500,000 JPY
JPY
Effect of exchange rate change on cash and cash equivalents
-96,979,000 JPY
-76,521,000 JPY
Net increase (decrease) in cash and cash equivalents
473,443,000 JPY
1,038,625,000 JPY
Cash and cash equivalents
3,321,029,000 JPY
2,798,635,000 JPY
3,380,241,000 JPY
2,341,616,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.